HEADER TRANSFERASE 03-MAY-18 6DBN TITLE JAK1 WITH COMPOUND 23 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: JANUS KINASE 1,JAK-1; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK1, JAK1A, JAK1B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF21 KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 2 07-NOV-18 6DBN 1 JRNL REVDAT 1 29-AUG-18 6DBN 0 JRNL AUTH A.FENSOME,C.M.AMBLER,E.ARNOLD,M.E.BANKER,M.F.BROWN, JRNL AUTH 2 J.CHRENCIK,J.D.CLARK,M.E.DOWTY,I.V.EFREMOV,A.FLICK, JRNL AUTH 3 B.S.GERSTENBERGER,A.GOPALSAMY,M.M.HAYWARD,M.HEGEN, JRNL AUTH 4 B.D.HOLLINGSHEAD,J.JUSSIF,J.D.KNAFELS,D.C.LIMBURG,D.LIN, JRNL AUTH 5 T.H.LIN,B.S.PIERCE,E.SAIAH,R.SHARMA,P.T.SYMANOWICZ, JRNL AUTH 6 J.B.TELLIEZ,J.I.TRUJILLO,F.F.VAJDOS,F.VINCENT,Z.K.WAN, JRNL AUTH 7 L.XING,X.YANG,X.YANG,L.ZHANG JRNL TITL DUAL INHIBITION OF TYK2 AND JAK1 FOR THE TREATMENT OF JRNL TITL 2 AUTOIMMUNE DISEASES: DISCOVERY OF (( JRNL TITL 3 S)-2,2-DIFLUOROCYCLOPROPYL)((1 R,5 S)-3-(2-((1-METHYL-1 JRNL TITL 4 H-PYRAZOL-4-YL)AMINO)PYRIMIDIN-4-YL)-3, JRNL TITL 5 8-DIAZABICYCLO[3.2.1]OCTAN-8-YL)METHANONE (PF-06700841). JRNL REF J. MED. CHEM. V. 61 8597 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30113844 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00917 REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 10500 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.390 REMARK 3 FREE R VALUE TEST SET COUNT : 566 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.77 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.15 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2781 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2366 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2634 REMARK 3 BIN R VALUE (WORKING SET) : 0.2309 REMARK 3 BIN FREE R VALUE : 0.3478 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.29 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 147 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2286 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.82 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.62890 REMARK 3 B22 (A**2) : 6.78300 REMARK 3 B33 (A**2) : -10.41190 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.315 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.204 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.316 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.844 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.314 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2407 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3273 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 862 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 60 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 354 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2407 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 295 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2794 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.19 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.04 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.11 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DBN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1000234336. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.3.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10653 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 72.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.36800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.5, 6-9% MPD, 24-29% REMARK 280 PEG-1500, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.95700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.95700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 22.75500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.21100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 22.75500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.21100 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 72.95700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 22.75500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.21100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 72.95700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 22.75500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 44.21100 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A4116 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 839 REMARK 465 SER A 840 REMARK 465 ILE A 841 REMARK 465 MET A 842 REMARK 465 ARG A 843 REMARK 465 ASP A 844 REMARK 465 ILE A 845 REMARK 465 ASN A 846 REMARK 465 LYS A 847 REMARK 465 LEU A 848 REMARK 465 GLU A 849 REMARK 465 GLU A 850 REMARK 465 GLN A 851 REMARK 465 ASN A 852 REMARK 465 PRO A 853 REMARK 465 ASP A 854 REMARK 465 ILE A 855 REMARK 465 VAL A 856 REMARK 465 SER A 857 REMARK 465 GLU A 858 REMARK 465 LYS A 859 REMARK 465 LYS A 860 REMARK 465 PRO A 861 REMARK 465 ALA A 862 REMARK 465 THR A 863 REMARK 465 GLU A 864 REMARK 465 VAL A 865 REMARK 465 ASP A 866 REMARK 465 GLU A 913 REMARK 465 SER A 914 REMARK 465 GLY A 915 REMARK 465 GLY A 916 REMARK 465 ASP A 947 REMARK 465 GLY A 948 REMARK 465 GLY A 949 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 912 CG CD REMARK 470 GLU A1029 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS A 918 C - N - CA ANGL. DEV. = 16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 878 -60.25 -107.80 REMARK 500 ASP A 895 70.99 -117.30 REMARK 500 HIS A 918 -22.40 107.01 REMARK 500 ARG A1002 -1.99 70.35 REMARK 500 ASP A1003 42.35 -141.72 REMARK 500 ASP A1031 -12.02 74.02 REMARK 500 LYS A1038 -82.01 -82.25 REMARK 500 ASP A1039 -70.23 -62.52 REMARK 500 ASP A1040 70.38 55.86 REMARK 500 SER A1056 16.92 58.02 REMARK 500 TYR A1077 28.22 49.54 REMARK 500 THR A1095 -51.03 -146.03 REMARK 500 HIS A1096 139.37 69.54 REMARK 500 ASN A1119 -5.74 84.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LYS A 911 10.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4190 DISTANCE = 7.73 ANGSTROMS REMARK 525 HOH A4191 DISTANCE = 9.44 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G4J A 4000 DBREF 6DBN A 841 1154 UNP P23458 JAK1_HUMAN 841 1154 SEQADV 6DBN GLY A 839 UNP P23458 EXPRESSION TAG SEQADV 6DBN SER A 840 UNP P23458 EXPRESSION TAG SEQRES 1 A 316 GLY SER ILE MET ARG ASP ILE ASN LYS LEU GLU GLU GLN SEQRES 2 A 316 ASN PRO ASP ILE VAL SER GLU LYS LYS PRO ALA THR GLU SEQRES 3 A 316 VAL ASP PRO THR HIS PHE GLU LYS ARG PHE LEU LYS ARG SEQRES 4 A 316 ILE ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS VAL GLU SEQRES 5 A 316 LEU CYS ARG TYR ASP PRO GLU GLY ASP ASN THR GLY GLU SEQRES 6 A 316 GLN VAL ALA VAL LYS SER LEU LYS PRO GLU SER GLY GLY SEQRES 7 A 316 ASN HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU ILE LEU SEQRES 8 A 316 ARG ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR LYS GLY SEQRES 9 A 316 ILE CYS THR GLU ASP GLY GLY ASN GLY ILE LYS LEU ILE SEQRES 10 A 316 MET GLU PHE LEU PRO SER GLY SER LEU LYS GLU TYR LEU SEQRES 11 A 316 PRO LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN GLN LEU SEQRES 12 A 316 LYS TYR ALA VAL GLN ILE CYS LYS GLY MET ASP TYR LEU SEQRES 13 A 316 GLY SER ARG GLN TYR VAL HIS ARG ASP LEU ALA ALA ARG SEQRES 14 A 316 ASN VAL LEU VAL GLU SER GLU HIS GLN VAL LYS ILE GLY SEQRES 15 A 316 ASP PHE GLY LEU THR LYS ALA ILE GLU THR ASP LYS GLU SEQRES 16 A 316 PTR PTR THR VAL LYS ASP ASP ARG ASP SER PRO VAL PHE SEQRES 17 A 316 TRP TYR ALA PRO GLU CYS LEU MET GLN SER LYS PHE TYR SEQRES 18 A 316 ILE ALA SER ASP VAL TRP SER PHE GLY VAL THR LEU HIS SEQRES 19 A 316 GLU LEU LEU THR TYR CYS ASP SER ASP SER SER PRO MET SEQRES 20 A 316 ALA LEU PHE LEU LYS MET ILE GLY PRO THR HIS GLY GLN SEQRES 21 A 316 MET THR VAL THR ARG LEU VAL ASN THR LEU LYS GLU GLY SEQRES 22 A 316 LYS ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP GLU VAL SEQRES 23 A 316 TYR GLN LEU MET ARG LYS CYS TRP GLU PHE GLN PRO SER SEQRES 24 A 316 ASN ARG THR SER PHE GLN ASN LEU ILE GLU GLY PHE GLU SEQRES 25 A 316 ALA LEU LEU LYS MODRES 6DBN PTR A 1034 TYR MODIFIED RESIDUE MODRES 6DBN PTR A 1035 TYR MODIFIED RESIDUE HET PTR A1034 16 HET PTR A1035 16 HET G4J A4000 49 HETNAM PTR O-PHOSPHOTYROSINE HETNAM G4J [(1S)-2,2-DIFLUOROCYCLOPROPYL][(1R,5S)-3-{2-[(1-METHYL- HETNAM 2 G4J 1H-PYRAZOL-4-YL)AMINO]PYRIMIDIN-4-YL}-3,8- HETNAM 3 G4J DIAZABICYCLO[3.2.1]OCTAN-8-YL]METHANONE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 G4J C18 H21 F2 N7 O FORMUL 3 HOH *91(H2 O) HELIX 1 AA1 GLU A 871 ARG A 873 5 3 HELIX 2 AA2 HIS A 918 ASN A 931 1 14 HELIX 3 AA3 SER A 963 LEU A 968 1 6 HELIX 4 AA4 PRO A 969 ASN A 971 5 3 HELIX 5 AA5 ASN A 976 ARG A 997 1 22 HELIX 6 AA6 ALA A 1005 ARG A 1007 5 3 HELIX 7 AA7 PRO A 1044 TYR A 1048 5 5 HELIX 8 AA8 ALA A 1049 SER A 1056 1 8 HELIX 9 AA9 ILE A 1060 THR A 1076 1 17 HELIX 10 AB1 ASP A 1079 SER A 1082 5 4 HELIX 11 AB2 SER A 1083 LEU A 1089 1 7 HELIX 12 AB3 THR A 1095 GLU A 1110 1 16 HELIX 13 AB4 PRO A 1121 CYS A 1131 1 11 HELIX 14 AB5 GLN A 1135 ARG A 1139 5 5 HELIX 15 AB6 SER A 1141 ALA A 1151 1 11 SHEET 1 AA1 5 LEU A 875 GLU A 883 0 SHEET 2 AA1 5 LYS A 888 TYR A 894 -1 O VAL A 889 N LEU A 881 SHEET 3 AA1 5 GLU A 903 SER A 909 -1 O VAL A 905 N CYS A 892 SHEET 4 AA1 5 ILE A 952 GLU A 957 -1 O MET A 956 N ALA A 906 SHEET 5 AA1 5 TYR A 940 THR A 945 -1 N GLY A 942 O ILE A 955 SHEET 1 AA2 2 TYR A 999 VAL A1000 0 SHEET 2 AA2 2 LYS A1026 ALA A1027 -1 O LYS A1026 N VAL A1000 SHEET 1 AA3 2 VAL A1009 SER A1013 0 SHEET 2 AA3 2 GLN A1016 ILE A1019 -1 O GLN A1016 N GLU A1012 SHEET 1 AA4 2 PTR A1034 THR A1036 0 SHEET 2 AA4 2 LYS A1057 TYR A1059 -1 O PHE A1058 N PTR A1035 LINK C GLU A1033 N PTR A1034 1555 1555 1.34 LINK C PTR A1034 N PTR A1035 1555 1555 1.34 LINK C PTR A1035 N THR A1036 1555 1555 1.34 CISPEP 1 ASN A 917 HIS A 918 0 13.74 SITE 1 AC1 16 LEU A 881 GLY A 882 GLU A 883 VAL A 889 SITE 2 AC1 16 ALA A 906 LYS A 908 GLU A 957 PHE A 958 SITE 3 AC1 16 LEU A 959 GLY A 962 GLU A 966 ARG A1007 SITE 4 AC1 16 LEU A1010 GLY A1020 ASP A1021 HOH A4137 CRYST1 45.510 88.422 145.914 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021973 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011309 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006853 0.00000